Search - tctmd.com

Displaying 581 - 600 of 691

Sort: Relevancy | Date

News Conference News ACC 2014

ARISTOTLE: Blood Pressure Adversely Affects Stroke Risk in A-fib Patients

Caitlin E. Cox

April 02, 2014

News Daily News

Los Pacientes Ancianos con SCA Reciben Menos Tratamiento Intensivo siendo Menores los Beneficios sobre la Supervivencia

Caitlin E. Cox

March 27, 2014

News Daily News

Elderly ACS Patients Receive Less Intensive Treatment, Survival Benefit Reduced

Caitlin E. Cox

March 27, 2014

News Daily News

Los Resultados SLF Varían según el Estado de la Diabetes y la Complejidad de la Lesión

Caitlin E. Cox

March 13, 2014

News Daily News

DES Outcomes Vary by Diabetes Status, Lesion Complexity

Caitlin E. Cox

March 13, 2014

News Daily News

与华法林或阿司匹林相比，阿哌沙班更具成本效益

Caitlin E. Cox

February 26, 2014

News Daily News

Apixaban es Rentable comparado con Warfarina o Aspirina

Caitlin E. Cox

February 26, 2014

News Daily News

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Caitlin E. Cox

February 26, 2014

News Daily News

Una Prueba No Invasiva asocia el Volumen de Fluido Pre-Angiografía a Futuros Daños Renales

Caitlin E. Cox

February 12, 2014

News Daily News

Noninvasive Test Links Pre-Angiography Fluid Volume to Later Kidney Damage

Caitlin E. Cox

February 12, 2014

News Daily News

高风险亚组从瑞舒伐他汀中获得肾脏保护

Caitlin E. Cox

October 11, 2013

News Daily News

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

Caitlin E. Cox

October 11, 2013

News Daily News

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Caitlin E. Cox

October 11, 2013

News Daily News

荟萃分析表明维生素C可减轻急性肾损伤

Caitlin E. Cox

September 13, 2013

News Daily News

Un Meta Análisis Sugiere que la Vitamina C Protege contra la Lesión Renal Aguda

Caitlin E. Cox

September 13, 2013

News Daily News

Meta-analysis Suggests Vitamin C Protective Against Acute Kidney Injury

Caitlin E. Cox

September 13, 2013

News Conference News ESC 2013

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

Caitlin E. Cox

September 04, 2013

News Conference News ESC 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Caitlin E. Cox

September 03, 2013

News Conference News ESC 2013

Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients

Caitlin E. Cox

September 02, 2013

News Conference News ESC 2013

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Caitlin E. Cox

September 01, 2013

Advertisement

ARISTOTLE: Blood Pressure Adversely Affects Stroke Risk in A-fib Patients

Los Pacientes Ancianos con SCA Reciben Menos Tratamiento Intensivo siendo Menores los Beneficios sobre la Supervivencia

Elderly ACS Patients Receive Less Intensive Treatment, Survival Benefit Reduced

Los Resultados SLF Varían según el Estado de la Diabetes y la Complejidad de la Lesión

DES Outcomes Vary by Diabetes Status, Lesion Complexity

与华法林或阿司匹林相比，阿哌沙班更具成本效益

Apixaban es Rentable comparado con Warfarina o Aspirina

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Una Prueba No Invasiva asocia el Volumen de Fluido Pre-Angiografía a Futuros Daños Renales

Noninvasive Test Links Pre-Angiography Fluid Volume to Later Kidney Damage

高风险亚组从瑞舒伐他汀中获得肾脏保护

Los Subgrupos de Alto Riesgo obtienen Protección Renal de la Rosuvastatina

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

荟萃分析表明维生素C可减轻急性肾损伤

Un Meta Análisis Sugiere que la Vitamina C Protege contra la Lesión Renal Aguda

Meta-analysis Suggests Vitamin C Protective Against Acute Kidney Injury

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients

TAO: Otamixaban Fails to Outshine Heparin Plus Eptifibatide in NSTE-ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content